Paxillin can regulate the integrity and contractility of E-cadherin-dependent junctions by controlling the balance of RhoA and Rac1 activities to regulate the integrity of cell–cell adhesion junctions, thereby maintaining the migration of breast cancer cell populations [64]. This evidence concerns the gene PXN and breast carcinoma.